A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria responsive to antibiotics once again.
Jørn Bolstad and his chemist colleagues hope that the substance will soon be able to tackle the tremendous problems associated with multidrug resistant tuberculosis (MDR-TB). But first, they need to find investors interested in getting the substance onto the market.
Before the development of penicillin, people dropped like flies in response to minor infections: in the lungs, in small cuts. Even pimples could grow to boils that killed. But one of the main killers prior to the discovery of antibiotics was tuberculosis.
The deadly infectious disease that typically affects the lungs has returned. It has developed a resistance to the majority of antibiotics that would otherwise kill the tuberculosis bacteria. Currently, the disease does not pose an imminent threat to Denmark or the West. However, resistant strains of the bacteria are nearing the region’s borders. This is one of the reasons why doctors around the world are busy trying to solve the problem of drug resistance.
The bacteria shed killing substances
While those bacteria that have developed a resistance remain vulnerable to antibiotics, they have developed an ability to shed bacteria killing substances before any damage is done to them. Colloquially, this is referred to as pooping the substance out, but the scientific formulation is that these bacteria activate an efflux pump.
Jørn Bolstad Christensen has isolated a substance able to block the efflux pump so that an antibiotic remains in bacteria until the bacteria dies.
You could say that we cure bacteria of their resistance, and slay them with antibiotics, explains Associate Professor Jørn Bolstad Christensen.
From antipsychotic to killing bacteria
Working with doctors Jette Kristiansen from the University of Southern Denmark and Oliver Hendricks from the King Christian X’s Hospital for Rheumatic Diseases in Gråsten, Denmark, Jørn Bolstad Christensen discovered that Thioridazin, an antipsychotic drug, was able to kill bacteria without any noticeably harmful effects upon humans. Still, the chemists had an idea that could make the substance more benign.
We now have a substance that is able to block the bacteria’s efflux pump. At very most, recipients of the medication may become slightly sluggish. This is also because very small doses are needed to affect the bacteria, says Jørn Bolstad Christensen.
Researchers hope for quick approval
Because Thioridazin is an approved drug, the research team hopes that the new anti-resistance medication, JEK 47, will be approved without going through the entire process that new pharmaceuticals are typically subjected to. If this is the case, JEK 47 will most likely be a cheap medication that a pharmaceuticals manufacturer could release quickly. However if an investor does not show interest, Christensen is certain about his next step.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- News tagged with antibiotic-resistant infectionson November 26, 2020 at 4:41 am
Medical Xpress is a web-based medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, ...
- Humans are polluting the environment with antibiotic-resistant bacteria, and I'm finding them everywhereon November 25, 2020 at 6:42 am
Many of us are aware of the enormous threat of antibiotic- (or "antimicrobial") resistant bacteria on human health. But few realize just how pervasive these superbugs are—antimicrobial-resistant ...
- Rising global temperatures tied to rising antibiotic resistanceon November 25, 2020 at 6:16 am
A new data analysis suggests that two rising public health threats—climate change and antibiotic resistance—are related. The study, spanning 2000 to 2016, doesn't establish cause and effect. But its ...
- Humans Are Polluting The Environment With Antibiotic-Resistant Bacteriaon November 25, 2020 at 6:00 am
Many of us are aware of the enormous threat of antibiotic- (or “antimicrobial”) resistant bacteria on human health. But few realise just how pervasive these superbugs are — antimicrobial-resistant ...
- Robotic Culture System Enables Mechanistic View of How Bacteria Evolve Drug Resistanceon November 25, 2020 at 4:00 am
Riken team hopes new findings may help scientists understand how to predict, and feasibly control, antibiotic resistance ...
- Inexpensive molecule shows potential to fight antibiotic-resistant bacteria causing gonorrhea, meningitison November 24, 2020 at 4:47 pm
A team from the Institut national de la recherche scientifique (INRS) has demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible ...
- Global Antibiotic Resistance Market 2020 Industry Overview, Competition by Manufacturers, Production Capacity by Region, Forecast by 2026on November 23, 2020 at 8:52 pm
Global Antibiotic Resistance Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 offers end to end industry from the definition, product specifications, and demand till ...
- Solving a mystery: How the TB bacterium develops rapid resistance to antibioticson November 19, 2020 at 2:58 pm
These slow growing bacteria have long puzzled TB researchers with their fairly rapid resistance to antibiotics. Researchers may have been barking up the wrong tree in exploring genetics, because the ...
- Alzheimer's disease drug may help fight against antibiotic resistanceon November 18, 2020 at 11:02 am
An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.
- Alzheimer’s Drug May Also Fight Antibiotic Resistanceon November 18, 2020 at 10:00 am
New research suggests that a drug previously made to help fight Alzheimer’s disease may also be uniquely effective at treating life-threatening bacteria that have grown resistant over time ...
via Bing News